Currently Forecasting

CompanyDrugTrial Result 
*AnaptysBio (ANAB)Imsidolimab for DermatologyPhase II GALLOP
*Sage (SAGE) / BiogenSAGE-217 for Major Depressive DisorderPhase III WATERFALL
*Imara (IMRA) / LundbeckIMR-687 for Sickle Cell AnemiaPhase IIb Ardent
*Vertex (VRTX)VX-147 for Focal Segmental Glomerulosclerosis Phase II
*Xenon (XENE)XEN1101 for Partial Seizures (Epilepsy)Phase IIb - X-TOLE
*SpringWorks (SWTX)Nirogacestat for Desmoid Tumors/Aggressive FibromatosisPhase III - DeFi
*Sanofi (SNY) (Principia)Rilzabrutinib (PRN1008) for Pemphigus VulgarisPhase III PEGASUS
*Galera (GRTX)Avasopasem (GC4419) for MucositisPhase III ROMAN
*Summit Therapeutics (SMMT)/ EurofarmaRidinilazole for CDAD/CDIPhase III Ri-CoDIFy 1 and 2
*AppellisPegcetacoplan for Dry AMD / Geographic AtrophyPhase III DERBY
Karyopharm TherapeuticsXpovioPhase III SIENDO
Allakos Inc.AK002Phase II/III KRYPTOS
ImmunoGenMirvetuximabPhase III SORAYA
ObsEva SALinzagolixPhase III EDELWEISS
Ayala PharmaceuticalsAL101Phase II TENACITY
Biohaven PharmaceuticalTroriluzolePhase III SARA
AbbVieCariprazinePhase III in MDD (2 Trials)
ACADIA PharmaceuticalsTrofinetidePhase III LAVENDER
Bristol-Myers Squibb/RegenacyRicolinostatPhase II
AegleaPegzilarginasePhase III PEACE
NovartisSecukinumabPhase III SUNSHINE/SUNRISEIL-17
CortexymeCOR288Phase II/III GAINLysine Gingipain (Protease)
Anavex Life Sciences Corp.ANAVEX 2-73Phase II/III AVATARSigma-1 and muscarinic receptors
Tonix Pharmaceuticals Holding Corp.TonmyaPhase III RALLYSerotonin-2A (5-HT2A) receptor, Alpha-1-adrenergic receptor, Histamine-1 receptor
Angion BiomedicaANG-3777Phase III GIFTHepatocyte Growth Factor Receptor
Stealth BioTherapeutics Inc.Elamipretide (Systemic Delivery)Phase II RECLAIM-2Cardiolipin

Do you have a specific trial you’d like Diviner to forecast? Let us know!

On June 30th, Diviner and Molecular Health unveiled their predictions for the results of the trials shown with an asterisk. Watch the recording of the event.

Register here for a deck on the trials we forecasted and our results.

We will send you briefing slides on the trials and a link to forecast the outcomes, and a summary of the results.

We will keep your participation confidential.